相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
Johannes Schetelig et al.
BONE MARROW TRANSPLANTATION (2021)
Pharmacological MEK inhibition promotes polyclonal T-cell reconstitution and suppresses xenogeneic GVHD
Hidekazu Itamura et al.
CELLULAR IMMUNOLOGY (2021)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
p27 controls Ragulator and mTOR activity in amino acid-deprived cells to regulate the autophagy-lysosomal pathway and coordinate cell cycle and cell growth
Ada Nowosad et al.
NATURE CELL BIOLOGY (2020)
Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation
Hidekazu Itamura et al.
BLOOD ADVANCES (2020)
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study
Brittany Knick Ragon et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD
Nisha Kurian et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2019)
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling
Petros Andrikopoulos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Determination of reliable lung function parameters in intubated mice
Eline Bonnardel et al.
RESPIRATORY RESEARCH (2019)
SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
Jonathan C. Poe et al.
JCI INSIGHT (2018)
Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation
Yang Quan-Jun et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Current Development Status of MEK Inhibitors
Ying Cheng et al.
MOLECULES (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David Miklos et al.
BLOOD (2017)
Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation
Danny Jonigk et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2017)
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production
Jing Du et al.
BLOOD (2017)
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
Kenneth R. Cooke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
Kirsten M. Williams et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation
C. Del Fante et al.
BONE MARROW TRANSPLANTATION (2016)
Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development
Ma Carmen Herrero-Sanchez et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2016)
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
David Planchard et al.
LANCET ONCOLOGY (2016)
The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects
Hidekazu Itamura et al.
JCI INSIGHT (2016)
Aberrant B-cell homeostasis in chronic GVHD
Stefanie Sarantopoulos et al.
BLOOD (2015)
Histological evolution of pleuroparenchymal fibroelastosis
Takako Hirota et al.
HISTOPATHOLOGY (2015)
Pleuroparenchymal fibroelastosis and non-specific interstitial pneumonia: frequent pulmonary sequelae of haematopoietic stem cell transplantation
Yasuhide Takeuchi et al.
HISTOPATHOLOGY (2015)
Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease
Jeanne Palmer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans
Ryan Flynn et al.
BLOOD (2014)
Plasmin Induces In Vivo Monocyte Recruitment through Protease-Activated Receptor-1-, MEK/ERK-, and CCR2-Mediated Signaling
Aline A. F. Carmo et al.
JOURNAL OF IMMUNOLOGY (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner
Takero Shindo et al.
BLOOD (2013)
Histologic findings in lung biopsies in patients with suspected graft-versus-host disease
Lauren Xu et al.
HUMAN PATHOLOGY (2013)
Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis
Efrat Ofek et al.
MODERN PATHOLOGY (2013)
A casecontrol study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Hideki Nakasone et al.
TRANSPLANT INTERNATIONAL (2013)
Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation
Gregory A. Yanik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
Mathangi Srinivasan et al.
BLOOD (2012)
Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels
F. Leonhardt et al.
LEUKEMIA (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation
Jan H. von der Thuesen et al.
MODERN PATHOLOGY (2011)
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M. Delgoffe et al.
NATURE IMMUNOLOGY (2011)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells
LJ Appleman et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
